SCHEMBL23389097

SCHEMBL23389097

C=CS(=O)(=O)N[C@@H]1CCCN(Cc2cc3cc(OC(F)(F)F)ccc3[nH]2)C1

nearest known ligand 0.44

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
▸ ROCK2 O75116 2/20 0.44
▸ JAK2 O60674 1/20 0.42
▸ PRKD3 O94806 1/20 0.42
▸ PRKCG P05129 1/20 0.42
▸ PHKG2 P15735 1/20 0.42
▸ RPS6KB1 P23443 1/20 0.42
▸ MARK3 P27448 1/20 0.42
▸ PRKCI P41743 1/20 0.42
▸ CLK2 P49760 1/20 0.42
▸ IRAK1 P51617 1/20 0.42
▸ RPS6KA3 P51812 1/20 0.42
▸ PRKCD Q05655 1/20 0.42
▸ MAP4K2 Q12851 1/20 0.42
▸ STK3 Q13188 1/20 0.42
▸ CAMK2B Q13554 1/20 0.42
▸ CAMK2G Q13555 1/20 0.42
▸ CAMK2D Q13557 1/20 0.42
▸ PKN2 Q16513 1/20 0.42
▸ CDC42BPA Q5VT25 1/20 0.42
▸ TAOK1 Q7L7X3 1/20 0.42

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL23389100 1.00 ROCK2 (0.44) ROCK2JAK2PRKD3PRKCGPHKG2
SCHEMBL25987671 0.86 BTK (0.38) ROCK2DDR1BTK
SCHEMBL23389189 0.85 ROCK2 (0.45) ROCK2KDM4EDDR1BCHEACHE
SCHEMBL23389186 0.85 ROCK2 (0.45) ROCK2KDM4EDDR1BCHEACHE
SCHEMBL29943544 0.79 DDR1 (0.47) ROCK2JAK2PRKD3PRKCGPHKG2
SCHEMBL23389143 0.79 DDR1 (0.47) ROCK2JAK2PRKD3PRKCGPHKG2
SCHEMBL23389145 0.79 DDR1 (0.47) ROCK2JAK2PRKD3PRKCGPHKG2
SCHEMBL23389118 0.79 ROCK2 (0.48) ROCK2JAK2PRKD3PRKCGPHKG2
SCHEMBL23389119 0.79 ROCK2 (0.48) ROCK2JAK2PRKD3PRKCGPHKG2
SCHEMBL23419028 0.76 HRH3 (0.52) ROCK2JAK2PRKD3PRKCGPHKG2

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 8 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20250263366-A2 CASPASE 6 INHIBITORS AND USES THEREOF SHANGPHARMA INNOVATION INC. 2025-08-21 — — US disclosed
US-20230202974-A1 CASPASE 6 INHIBITORS AND USES THEREOF UNIV CALIFORNIA (US) 2023-06-29 — — US disclosed
US-20230202974-A1 CASPASE 6 INHIBITORS AND USES THEREOF UNIV CALIFORNIA (US) 2023-06-29 — — US disclosed
US-20230202974-A1 CASPASE 6 INHIBITORS AND USES THEREOF UNIV CALIFORNIA (US) 2023-06-29 — — US disclosed
CN-115335039-A Caspase 6 inhibitors and uses thereof 加利福尼亚大学董事会 2022-11-11 — — CN disclosed
EP-4061341-A1 CASPASE 6 INHIBITORS AND USES THEREOF The Regents of the University of California (US) 2022-09-28 — — EP disclosed
WO-2021102361-A1 CASPASE 6 INHIBITORS AND USES THEREOF THE REGENTS OF THE UNIVERSITY OF CALIFORNIA (US) 2021-05-27 — — WO disclosed
WO-2021102361-A1 CASPASE 6 INHIBITORS AND USES THEREOF THE REGENTS OF THE UNIVERSITY OF CALIFORNIA (US) 2021-05-27 — — WO disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20230202974-A1 CASPASE 6 INHIBITORS AND USES THEREOF CASP6, CASP1, CASP10 ROCK2 3549/4885JAK2 2359/4885PRKD3 2151/4885
US-20250263366-A2 CASPASE 6 INHIBITORS AND USES THEREOF CASP6, CASP1, CASP10 ROCK2 3549/4885JAK2 2359/4885PRKD3 2151/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.

Send feedback